These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 22086850)

  • 61. Mechanism of active transcriptional repression by the retinoblastoma protein.
    Weintraub SJ; Chow KN; Luo RX; Zhang SH; He S; Dean DC
    Nature; 1995 Jun; 375(6534):812-5. PubMed ID: 7596417
    [TBL] [Abstract][Full Text] [Related]  

  • 62. RB activity alters checkpoint response and chemosensitivity in lung cancer lines.
    Reed MF; Zagorski WA; Knudsen ES
    J Surg Res; 2007 Oct; 142(2):364-72. PubMed ID: 17640669
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Geminin is targeted for repression by the retinoblastoma tumor suppressor pathway through intragenic E2F sites.
    Markey M; Siddiqui H; Knudsen ES
    J Biol Chem; 2004 Jul; 279(28):29255-62. PubMed ID: 15084580
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A retinoblastoma-binding protein that affects cell-cycle control and confers transforming ability.
    Woitach JT; Zhang M; Niu CH; Thorgeirsson SS
    Nat Genet; 1998 Aug; 19(4):371-4. PubMed ID: 9697699
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Rb family-independent activating E2F increases genome stability, promotes homologous recombination, and decreases non-homologous end joining.
    Pei X; Du E; Sheng Z; Du W
    Mech Dev; 2020 Jun; 162():103607. PubMed ID: 32217105
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Distinct and overlapping roles of ARID3A and ARID3B in regulating E2F‑dependent transcription via direct binding to E2F target genes.
    Saadat KASM; Lestari W; Pratama E; Ma T; Iseki S; Tatsumi M; Ikeda MA
    Int J Oncol; 2021 Apr; 58(4):. PubMed ID: 33649863
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Differential regulation of apoptotic genes by Rb in human versus mouse cells.
    Young AP; Longmore GD
    Oncogene; 2004 Apr; 23(15):2587-99. PubMed ID: 15048095
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Tandem E2F binding sites in the promoter of the p107 cell cycle regulator control p107 expression and its cellular functions.
    Burkhart DL; Wirt SE; Zmoos AF; Kareta MS; Sage J
    PLoS Genet; 2010 Jun; 6(6):e1001003. PubMed ID: 20585628
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Transient accumulation of retinoblastoma/E2F-1 protein complexes correlates with the onset of neuronal differentiation in the developing quail neural retina.
    Kastner A; Espanel X; Brun G
    Cell Growth Differ; 1998 Oct; 9(10):857-67. PubMed ID: 9790497
    [TBL] [Abstract][Full Text] [Related]  

  • 70. LXCXE-independent chromatin remodeling by Rb/E2f mediates neuronal quiescence.
    Andrusiak MG; Vandenbosch R; Dick FA; Park DS; Slack RS
    Cell Cycle; 2013 May; 12(9):1416-23. PubMed ID: 23574720
    [TBL] [Abstract][Full Text] [Related]  

  • 71. A dual role for the dREAM/MMB complex in the regulation of differentiation-specific E2F/RB target genes.
    Lee H; Ragusano L; Martinez A; Gill J; Dimova DK
    Mol Cell Biol; 2012 Jun; 32(11):2110-20. PubMed ID: 22451490
    [TBL] [Abstract][Full Text] [Related]  

  • 72. RBF binding to both canonical E2F targets and noncanonical targets depends on functional dE2F/dDP complexes.
    Korenjak M; Anderssen E; Ramaswamy S; Whetstine JR; Dyson NJ
    Mol Cell Biol; 2012 Nov; 32(21):4375-87. PubMed ID: 22927638
    [TBL] [Abstract][Full Text] [Related]  

  • 73. An oncolytic adenovirus selective for retinoblastoma tumor suppressor protein pathway-defective tumors: dependence on E1A, the E2F-1 promoter, and viral replication for selectivity and efficacy.
    Jakubczak JL; Ryan P; Gorziglia M; Clarke L; Hawkins LK; Hay C; Huang Y; Kaloss M; Marinov A; Phipps S; Pinkstaff A; Shirley P; Skripchenko Y; Stewart D; Forry-Schaudies S; Hallenbeck PL
    Cancer Res; 2003 Apr; 63(7):1490-9. PubMed ID: 12670895
    [TBL] [Abstract][Full Text] [Related]  

  • 74. YB-1, the E2F pathway, and regulation of tumor cell growth.
    Lasham A; Samuel W; Cao H; Patel R; Mehta R; Stern JL; Reid G; Woolley AG; Miller LD; Black MA; Shelling AN; Print CG; Braithwaite AW
    J Natl Cancer Inst; 2012 Jan; 104(2):133-46. PubMed ID: 22205655
    [TBL] [Abstract][Full Text] [Related]  

  • 75. DNMT1 forms a complex with Rb, E2F1 and HDAC1 and represses transcription from E2F-responsive promoters.
    Robertson KD; Ait-Si-Ali S; Yokochi T; Wade PA; Jones PL; Wolffe AP
    Nat Genet; 2000 Jul; 25(3):338-42. PubMed ID: 10888886
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A genetic analysis of the E2F1 gene distinguishes regulation by Rb, p107, and adenovirus E4.
    Cress WD; Johnson DG; Nevins JR
    Mol Cell Biol; 1993 Oct; 13(10):6314-25. PubMed ID: 8413230
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Rb and E2F-1 regulate telomerase activity in human cancer cells.
    Crowe DL; Nguyen DC
    Biochim Biophys Acta; 2001 Mar; 1518(1-2):1-6. PubMed ID: 11267653
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identification of novel pRb binding sites using CpG microarrays suggests that E2F recruits pRb to specific genomic sites during S phase.
    Wells J; Yan PS; Cechvala M; Huang T; Farnham PJ
    Oncogene; 2003 Mar; 22(10):1445-60. PubMed ID: 12629508
    [TBL] [Abstract][Full Text] [Related]  

  • 79. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Differential activities of E2F family members: unique functions in regulating transcription.
    Pierce AM; Schneider-Broussard R; Philhower JL; Johnson DG
    Mol Carcinog; 1998 Jul; 22(3):190-8. PubMed ID: 9688145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.